Balloon animals

A quick apology to readers of this blog. I really enjoy writing here, but the past month has thrown up a number of challenges. One of these challenges is actually finding something interesting and, importantly, new, to write about. There are so many bloggers out there that I feel I would be doing you a […]

Read More Balloon animals

Social media sharing for pharma

I probably don’t need to tell you that there has been buzz recently about the new FDA guidance on social media that is predicted to appear in this year Indeed, John Mack predicted that the guidance would be issued in sections, and he puts forward a theory that guidance on short-format or space-limited communications will […]

Read More Social media sharing for pharma

DigiPharm Europe 2010 Pt 7

Here’s my final post on the #DigiPharm narrative. Part 7! Again, I am reporting on selected sessions from Day 2, ones that I found of note or interest. You can read the twitterstream for more information on the presentations not covered here. Part 1 Part 2 Part 3 Part 4 Part 5 Part 6 Still […]

Read More DigiPharm Europe 2010 Pt 7

DigiPharm Europe 2010 Pt 6

So here’s the penultimate part of this week-long series. Today I am focusing on the morning session of Day 2 of DigiPharm 2010 and the concluding blog post tomorrow will cover the afternoon session. I will not cover every presentation from Day 2, just the ones that had impact with the audience. Part 1 Part […]

Read More DigiPharm Europe 2010 Pt 6

DigiPharm Europe 2010 Pt 5

Once more unto the DigiPharm breach. Part 1 Part 2 Part 3 Part 4 Part 6 Part 7 Building up to reportable adverse events When last we spoke, I covered patient community discussions. We now turn our attention to reportable adverse events and the Internet presented by Daniel Ghinn and Paul Grant. They start by […]

Read More DigiPharm Europe 2010 Pt 5

DigiPharm Europe 2010 Pt 4

And to the next instalment of this series on DigiPharm Europe 2010. Part 1 Part 2 Part 3 Part 5 Part 6 Part 7 When is a community not a community? The session entitled “Community management in Pharma” was presented by René Vvan den Bos and Erik Van der Zijden. They focused on mythical ailment […]

Read More DigiPharm Europe 2010 Pt 4

DigiPharm Europe 2010 Pt 3

Third in the series of posts about the proceedings from DigiPharm Europe 2010. Part 1 Part 2 Part 4 Part 5 Part 6 Part 7 Mixing print and digtal So on to the second presentation of the day, where Mark Prince presented on integration of online and offline strategy. Prince rejects the practice of using […]

Read More DigiPharm Europe 2010 Pt 3

DigiPharm Europe 2010 Pt 2

Part 1 Part 3 Part 4 Part 5 Part 6 Part 7 Here I continue the commentary on the discussions surrounding topics from DigiPharm Europe 2010. We left off around halfway through Kai Gait’s presentation on business organisation for a digital future in Part 1, which can be found here. Gait says that fear of […]

Read More DigiPharm Europe 2010 Pt 2

Check-in to your GP?

Personally, I don’t hold much truck with Facebook on a social level (maybe I shouldn’t say that considering that technology, digital and social media is my day job!) and I prefer LinkedIn for business networking and Twitter for status updates and to quick-share information. And when I am mobile, on the go? SMS and again […]

Read More Check-in to your GP?